SER logo

Serina Therapeutics (SER) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$532.20 K
+$217.40 K+69.06%

31 December 2022

SER Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Cash And Cash Equivalents

$3.19 M
-$2.88 M-47.48%

30 September 2024

SER Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SER Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years+69.1%-
5 y5 years--

SER Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+69.1%-63.5%+498.5%
5 y5 yearsat high+69.1%-63.5%+498.5%
alltimeall timeat high+69.1%-63.5%+498.5%

Serina Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sept 2024
-
$3.19 M(-47.5%)
June 2024
-
$6.06 M(-30.3%)
Mar 2024
-
$8.71 M(-0.2%)
DateAnnualQuarterly
June 2023
-
$8.72 M(+1538.9%)
Dec 2022
$532.20 K(+69.1%)
-
Dec 2022
-
$532.20 K
Dec 2021
$314.80 K
-

FAQ

  • What is Serina Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Serina Therapeutics?
  • What is Serina Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Serina Therapeutics?

What is Serina Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of SER is $532.20 K

What is the all time high annual cash & cash equivalents for Serina Therapeutics?

Serina Therapeutics all-time high annual cash & cash equivalents is $532.20 K

What is Serina Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of SER is $3.19 M

What is the all time high quarterly cash and cash equivalents for Serina Therapeutics?

Serina Therapeutics all-time high quarterly cash and cash equivalents is $8.72 M